GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Inflammation mediated evolving changes in synapse structural integrity and dynamics in vivo in a mouse model of multiple sclerosis

$173,448
Rebecca Lynn Gillani · Massachusetts General Hospital · K08 · FY2018 · NS

Inflammation mediated evolving changes in synapse structural integrity and dynamics in vivo in a mouse model of multiple sclerosis

$173,448
Rebecca Lynn Gillani · Massachusetts General Hospital · K08 · FY2022 · NS

Inflammation mediated evolving changes in synapse structural integrity and dynamics in vivo in a mouse model of multiple sclerosis

$173,448
Rebecca Lynn Gillani · Massachusetts General Hospital · K08 · FY2020 · NS

Inflammation mediated evolving changes in synapse structural integrity and dynamics in vivo in a mouse model of multiple sclerosis

$173,448
Rebecca Lynn Gillani · Massachusetts General Hospital · K08 · FY2021 · NS

Mechanoregulation of the Leukocyte Specific Integrin LFA-1 by the Actin Cytoskeleton

$173,405
Travis I Moore · Boston Children'S Hospital · K01 · FY2019 · HL

Autoantibody-mediated demyelination in SFV-infected mice

$173,348
Maimonides Medical Center (Brooklyn) · R01 · FY2003 · NS

Autoantibody-mediated demyelination in SFV-infected mice

$173,348
Maimonides Medical Center (Brooklyn) · R01 · FY2002 · NS

Role of Proteasome Inhibition in the Pathogenesis of CADASIL

$173,340
Michael M Wang · University Of Michigan At Ann Arbor · K02 · FY2007 · NS

Targeted Ion Channel Downregulation By Nanoparticles: A Novel Therapeutic approa

$173,294
Laura Conforti · University Of Cincinnati · R21 · FY2012 · AR

Excitotoxicity in EAE

$173,250
David E. Pleasure · University Of California At Davis · R01 · FY2009 · NS

Assessing Cognitive Overload in People with Multiple Sclerosis

$173,232
Alyssa Nicole Nylander · University Of California, San Francisco · K23 · FY2025 · HD

Dose and Treatment Selection in Clinical Trials

$173,206
Ying Kuen Cheung · Columbia University Health Sciences · R01 · FY2006 · NS

In Vivo Brain Dialysis of Neuropeptides and Neuroimmune Signaling Proteins

$173,149
Julie A Stenken · University Of Arkansas At Fayetteville · R21 · FY2012 · NS

Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome

$173,115
Lee Ann Garrett-Sinha · State University Of New York At Buffalo · K18 · FY2023 · DE

Isolation and Characterization of a Ferritin Receptor

$173,091
Pennsylvania State Univ Hershey Med Ctr · R21 · FY2005 · NS

Isolation and Characterization of a Ferritin Receptor

$173,091
Pennsylvania State Univ Hershey Med Ctr · R21 · FY2004 · NS

SBIR Phase I: Implementation of an In Silico Antibody Engineering Environment to engineer therapeutic antibodies

$172,987
Juan C Almagro · Globalbio, Inc. · · FY2015 · TIP

Mass Spectrometry, Proteomics and Metabolomics Core

$172,953
John M Asara · Brigham And Women'S Hospital · P01 · FY2013 · CA

IMMUNE MECHANISMS UNDERLYING GENDER DIFFERENCES IN EAE

$172,939
University Of California Los Angeles · R01 · FY2000 · NS

Patient Oriented Research in Vitamin D and Physical Functioning in CKD

$172,917
Mary Beth Leonard · Children'S Hosp Of Philadelphia · K24 · FY2009 · DK

CD8 T Lymphocyte Regulation of EAE Disease Phenotype

$172,881
Yale University · K02 · FY2005 · NS

CD8 T Lymphocyte Regulation of EAE Disease Phenotype

$172,881
Yale University · K02 · FY2004 · NS

CD8 T Lymphocyte Regulation of EAE Disease Phenotype

$172,881
Michael D Carrithers · Yale University · K02 · FY2006 · NS

Neuronal Survival, HIV-1 and Astrocyte-TIMP-1

$172,701
Anuja Ghorpade · University Of Nebraska Medical Center · R01 · FY2007 · NS

Preclinical Studies of Rapamycin for TSC Brain Disease

$172,664
Brigham And Women'S Hospital · U01 · FY2004 · NS